collection
MENU ▼
Read by QxMD icon Read
search

Carbetocina

shared collection
12 papers 0 to 25 followers
By Nori Norero MR Anestesiologia
https://www.readbyqxmd.com/read/25266913/withdrawn-carbetocin-versus-oxytocin-for-prevention-of-postpartum-hemorrhage-a-randomised-controlled-trial
#1
Sergio Rosales Ortiz, Rogelio Aguado Perez, Roberto Sánchez Hernandez, Maria Inés Yt Castorena, Flor Gabriela Lucas Cristobal, Miriam Azenet Carbajal Gonzalez, Ioannis D Gallos, Arri Coomarasamy
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
September 16, 2014: European Journal of Obstetrics, Gynecology, and Reproductive Biology
https://www.readbyqxmd.com/read/24724226/postpartum-uterine-response-to-oxytocin-and-carbetocin
#2
COMPARATIVE STUDY
Hagai Amsalem, Clive J Aldrich, Marilynne Oskamp, Rory Windrim, Dan Farine
OBJECTIVE: To obtain quantitative data on uterine contractility postpartum and compare the response of intramuscular oxytocin to carbetocin. STUDY DESIGN: A prospective study using an intrauterine pressure transducer (IUPT) to measure frequency, amplitude, and duration of contractions following the administration of either oxytocin (10 U) or carbetocin (30 microg). RESULTS: The IUPT was tolerated by all subjects and generated useful data 90% of the time in most subjects (12/16)...
March 2014: Journal of Reproductive Medicine
https://www.readbyqxmd.com/read/24158878/carbetocin-at-elective-cesarean-delivery-a-randomized-controlled-trial-to-determine-the-effective-dose-part-2
#3
RANDOMIZED CONTROLLED TRIAL
Suresh Anandakrishnan, Mrinalini Balki, Dan Farine, Gareth Seaward, Jose C A Carvalho
PURPOSE: The aim of this study was to determine the intravenous dose of carbetocin required to produce effective uterine contraction in 95% of women (ED95) undergoing elective Cesarean delivery under spinal anesthesia. METHODS: One hundred and twenty term pregnant women at low risk for postpartum hemorrhage (PPH) undergoing elective Cesarean delivery under spinal anesthesia were randomly allocated to receive carbetocin in doses of 20, 40, 60, 80, or 100 μg iv upon delivery of the fetus...
November 2013: Canadian Journal of Anaesthesia, Journal Canadien D'anesthésie
https://www.readbyqxmd.com/read/24092476/pharmacologic-intervention-for-managing-uterine-atony-and-related-maternal-hemorrhage-what-is-the-most-effective-drug-dose
#4
Holly A Muir
No abstract text is available yet for this article.
November 2013: Canadian Journal of Anaesthesia, Journal Canadien D'anesthésie
https://www.readbyqxmd.com/read/23598289/changes-in-blood-pressure-and-cardiac-output-during-cesarean-delivery-the-effects-of-oxytocin-and-carbetocin-compared-with-placebo
#5
RANDOMIZED CONTROLLED TRIAL
Leiv Arne Rosseland, Tor Hugo Hauge, Guro Grindheim, Audun Stubhaug, Eldrid Langesæter
BACKGROUND: Little is known about maternal hemodynamics after Cesarean delivery. Uterine contractions may increase cardiac output. Oxytocin is the first-line treatment for uterine atony, although the effects of the long-acting oxytocin analogue carbetocin are comparable with that of oxytocin. The authors analyzed the effects of i.v. oxytocin 5 U, carbetocin 100 µg, and placebo on hemodynamics, uterine tone, adverse events, and blood loss after Cesarean delivery. METHODS: This was a randomized, double-blinded, placebo-controlled, parallel-group comparison of carbetocin and oxytocin after elective Cesarean delivery of singletons under spinal anesthesia (n = 76)...
September 2013: Anesthesiology
https://www.readbyqxmd.com/read/23329341/carbetocin-in-comparison-with-oxytocin-in-several-dosing-regimens-for-the-prevention-of-uterine-atony-after-elective-caesarean-section-in-the-netherlands
#6
COMPARATIVE STUDY
C A G Holleboom, J van Eyck, S V Koenen, I A M Kreuwel, F Bergwerff, E C Creutzberg, H W Bruinse
PURPOSE: The aim of the study was to compare the prophylactic effects of carbetocin with those of oxytocin for the prevention of uterine atony in patients undergoing elective caesarean section (CS) in the Netherlands. The primary endpoint was the need for additional uterotonic medication. METHODS: Each of the five participating Dutch hospitals treated 50-100 term patients with 100 μg of intravenous carbetocin on prescription. Each centre retrieved charts of 250 patients treated with oxytocin according to the hospital's policy for the prevention of uterine atony (oxytocin bolus 5 IU, bolus 10 IU or bolus 5 IU followed by 10 IU in 2 h)...
June 2013: Archives of Gynecology and Obstetrics
https://www.readbyqxmd.com/read/23122840/-clinical-and-pharmacological-study-of-the-efficacy-of-carbetocin-in-elective-caesareans-compared-to-low-and-usual-doses-of-oxytocin
#7
RANDOMIZED CONTROLLED TRIAL
J R Ortiz-Gómez, F Morillas-Ramírez, I Fornet-Ruiz, F J Palacio-Abizanda, L Bermejo-Albares
OBJECTIVES: To evaluate uterine contractility, bleeding, haemodynamic performance, and side effects of different doses of oxytocin after delivery under spinal anaesthesia in caesarean section without prior labour in childbirth. We also perform a pharmacoeconomic evaluation. MATERIAL AND METHODS: A randomised, descriptive, observational and multicentre prospective study was conducted, which included 104 ASA 1 patients divided into 3 groups. Group 1 (n=52) received after removal of the foetus and coinciding with foetal umbilical cord clamping, 1 IU of oxytocin followed by an infusion of 2...
January 2013: Revista Española de Anestesiología y Reanimación
https://www.readbyqxmd.com/read/22717890/carbetocin-at-elective-cesarean-delivery-a-randomized-controlled-trial-to-determine-the-effective-dose
#8
RANDOMIZED CONTROLLED TRIAL
Daniel Cordovani, Mrinalini Balki, Dan Farine, Gareth Seaward, Jose C A Carvalho
PURPOSE: The primary objective of our study was to determine the minimum intravenous dose of carbetocin required to produce adequate uterine contraction in 95% of women (effective dose [ED](95)) undergoing elective Cesarean delivery (CD). METHODS: Eighty term pregnant women with low risk for postpartum hemorrhage (PPH) undergoing elective CD under spinal anesthesia were randomly allocated to receive carbetocin intravenously in doses of 80 μg, 90 μg, 100 μg, 110 μg, or 120 μg upon delivery...
August 2012: Canadian Journal of Anaesthesia, Journal Canadien D'anesthésie
https://www.readbyqxmd.com/read/22513931/carbetocin-for-preventing-postpartum-haemorrhage
#9
REVIEW
Lin-Lin Su, Yap-Seng Chong, Miny Samuel
BACKGROUND: Postpartum haemorrhage (PPH) is one of the major contributors to maternal mortality and morbidity worldwide. Active management of the third stage of labour has been proven to be effective in the prevention of PPH. Syntometrine is more effective than oxytocin but is associated with more side effects. Carbetocin, a long-acting oxytocin agonist, appears to be a promising agent for the prevention of PPH. OBJECTIVES: To determine if the use of oxytocin agonist is as effective as conventional uterotonic agents for the prevention of PPH, and assess the best routes of administration and optimal doses of oxytocin agonist...
2012: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/22480555/-update-on-the-use-of-uterotonic-agents
#10
S Manrique Muñoz, F Munar Bauzà, S Francés González, M C Suescun López, N Montferrer Estruch, C Fernández López de Hierro
Postpartum haemorrhage (PPH) is defined by the WHO as a blood loss >500mL after vaginal delivery or >1000mL after caesarean section during the first 24hours post-delivery. Although the incidence of maternal mortality caused by PPH has decreased, it continues to be the major cause of maternal mortality due to obstetric haemorrhage. Furthermore, the incidence of uterine atony, which is the most prevalent cause of PPH, is still increasing in both vaginal delivery and caesarean section. Although PPH occurs in more than two thirds of patients without any identifiable risk factor, a prolonged third stage of labour is the main risk factor...
February 2012: Revista Española de Anestesiología y Reanimación
https://www.readbyqxmd.com/read/22336812/carbetocin-for-preventing-postpartum-haemorrhage
#11
REVIEW
Lin-Lin Su, Yap-Seng Chong, Miny Samuel
BACKGROUND: Postpartum haemorrhage (PPH) is one of the major contributors to maternal mortality and morbidity worldwide. Active management of the third stage of labour has been proven to be effective in the prevention of PPH. Syntometrine is more effective than oxytocin but is associated with more side effects. Carbetocin, a long-acting oxytocin agonist, appears to be a promising agent for the prevention of PPH. OBJECTIVES: To determine if the use of oxytocin agonist is as effective as conventional uterotonic agents for the prevention of PPH, and assess the best routes of administration and optimal doses of oxytocin agonist...
2012: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/21761999/carbetocin-versus-oxytocin-after-caesarean-section-similar-efficacy-but-reduced-pain-perception-in-women-with-high-risk-of-postpartum-haemorrhage
#12
Maria De Bonis, Michela Torricelli, Licia Leoni, Paolo Berti, Valentina Ciani, Rosa Puzzutiello, Filiberto Maria Severi, Felice Petraglia
OBJECTIVE: To compare the effectiveness of carbetocin with oxytocin with respect to maintain adequate uterine tone and to reduce the incidence and severity of postpartum haemorrhage. Moreover safety, adverse effects and the need of additional medications were evaluated. METHODS: Prospective controlled clinical trial. We compared the effect of a single dose of carbetocin (n = 55) with oxytocin infusion (n = 55) in a women population undergoing to elective caesarean section with regional subarachnoid anaesthesia with at least one risk factor for postpartum haemorrhage...
June 2012: Journal of Maternal-fetal & Neonatal Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"